FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| SKNV | 080105003 | 72934-1342 | 72934-1342-2 | Tretinoin; Salicylic Acid; Imiquimod | .1 g/100 mL; 30 g/100 mL; 5 g/100 mL | 2024-2 | valid | 2026-10-21 | |
| SKNV | 72934-1342 | 72934-1342-2 | Quidroxzar Gel | 021030 IMIQUIMOD 5% / SALICYLIC ACID 30% / TRETINOIN 0.1% Gel | .1 g/100 mL; 30 g/100 mL; 5 g/100 mL | 2024-2 | valid | 2026-09-18 | |
| SKNV | 080105003 | 72934-1342 | 72934-1342-2 | Tretinoin; Salicylic Acid; Imiquimod | .1 g/100 mL; 30 g/100 mL; 5 g/100 mL | 2024-1 | valid | 2026-10-21 | |
| SKNV | 080105003 | 72934-1342 | 72934-1342-2 | Tretinoin; Salicylic Acid; Imiquimod | .1 g/100 mL; 30 g/100 mL; 5 g/100 mL | 2023-2 | valid | 2026-10-21 | |
| SKNV | 080105003 | 72934-1342 | 72934-1342-2 | Salicylic Acid; Tretinoin; Imiquimod | 30 g/100 mL; .1 g/100 mL; 5 g/100 mL | 2022-1 | valid | 2026-10-21 |